Acurian, Inc. Announces Direct Access to Over 50% of Diagnosed Type 2 Diabetics for the Purpose of Clinical Trial Recruitment

HORSHAM, Pa.--(BUSINESS WIRE)--Acurian, Inc., a leading provider of patient recruitment solutions, announced today that its database of 50 million opted-in disease sufferers now includes over 50% of the 16 million diagnosed type 2 diabetics in the United States. According to the National Diabetes Information Clearinghouse, there are 17.9 million diagnosed diabetics in the United States, 90% of whom are estimated to have type 2 diabetes.